Skip to content
etf.net

Launched · SEC filings

Amplify Seymour Cannabis ETF

CNBSNYSE ArcaAmplifyC

$24.29+1.47 (+6.43%)

As of Nov 2, 2026, 3:48 PM ET

C46/ 100

Rank 3 of 5 in Cannabis

C46/100Rank 3 of 5inCannabis
Intraday session: up, 74 prints from 22.82 to 24.29. Range 22.82 to 24.66. Use the arrow keys to read each point.23.5024.0024.5010 AM12 PM2 PM4 PM
Expense ratio
0.76%*
Fund size
$63M
1Y total return
−16.3%
Yield · Last 12 months
0.00%
Holdings
36
Avg volume · 30D
5.21K sh
52W range
low $18.43high $43.94
Launched
Filings
SEC EDGAR

*After a fee waiver that ends Mar 1, 2027. Without it: 1.09%.

The ETF.net CNBS Grade

Based on 5 of 6 pillars

C

Score 46 out of 100

Category
Cannabis⁠
Rank
3 of 5
Six-pillar profile for CNBS. Scores out of 100: Cost 43, Risk 44, Mission not scored, Tradability 50, Holdings 48, Durability 61. Strongest: Durability (61). Weakest: Cost (43). Based on 5 of 6 pillars.

Score 46 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C43 out of 100
    Rank 2 of 5

  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored

  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    C44 out of 100
    Rank 2 of 5

  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C50 out of 100
    Rank 3 of 5

  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C48 out of 100
    Rank 3 of 5

  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    B61 out of 100
    Rank 2 of 5

Our read on CNBS

ETF.net Research

In short

CCannabis, undiluted. CNBS runs a roughly 30-stock portfolio built on a purity test: holdings must earn at least half their revenue from the cannabis and hemp ecosystem. Trading since 2019, it's a concentrated take on the theme, not a broad basket.

Stated mandate

The Fund seeks capital appreciation by investing in equity securities of companies engaged in cannabis and hemp-related activities. At least 80% of net assets is invested in companies deriving at least half of their revenue from the cannabis and hemp ecosystem.

Why people hold it

  • The purity rule is the whole point: at least 80% of assets go to companies earning half or more of their revenue from cannabis and hemp, so conglomerates with a side bet in the plant don't qualify.
  • About 30 names, which means each position actually moves the fund. A concentrated expression of the theme instead of a diluted sector sweep.
  • A plain 1940 Act fund operating since 2019: familiar ETF plumbing and 1099 tax reporting rather than a partnership K-1.

Worth knowing

  • The 1.09% expense ratio sits above the cannabis-fund median, and well above cheaper shelf-mates like WEED at 0.41% and MSOS at 0.81%. You're paying up in this aisle.
  • It trades lighter than the category's most active funds, so bid-ask spreads can be wider and size can push the price around.
  • The mandate is capital appreciation. Income isn't part of the design, and the fund has not been making distributions.

CNBS Holdings

Holdings pillarC48 out of 100Rank 3 of 5 in Cannabis
Asset class
Stocks
Holdings
36
Top-10 weight
152%
Largest holding
912797VP942.8%

Sectors

  • Health Care63.1%
  • Real Estate13.8%
  • Technology10.7%
  • Consumer Staples7.0%
  • Consumer Discretionary3.4%
  • Financials1.9%
  • Industrials0.1%

Geography

  • United States97.06%
  • Canada2.94%
The fund’s holdings, weight-ordered — page 1 of 3.
#TickerCompanyWeight %SharesMarket valueHeld by ETFs
1912797VP9United States Treasury Bill 11/03/202642.82%26,831,000$26.8M20
2912797VG9United States Treasury Bill 12/10/202628.72%18,070,000$18M50
3CURA.TOCuraleaf Holdings Inc15.94%1,184,846$9.98M9
4TRLVTrulieve Cannabis Corp15.63%952,658$9.79M11
5No dataGreen Thumb Inds Inc Swap Nbc-L14.41%1,440,249$9.03M1
6No dataTrulieve Cannabis Corp Swap Nbc-L12.31%750,259$7.71M1
7No dataVerano Hldgs Corp Swap Nbc-L7.68%959,883$4.81M1
8No dataCresco Labs Inc Swap Nbc-L5.75%6,292,675$3.6M1
9No dataCuraleaf Hldgs Swap Nbc-L4.75%359,567$2.97M1
10No dataTerrascend Corp Swap Nbc-L4.13%5,391,061$2.59M1
11IIPRInnovative Industrial Properties Inc3.16%38,099$1.98M104
12No dataTrulieve Cannabis Swap_r2.54%154,683$1.59M1
13No dataGlass House Brands Inc Swap Nbc-L2.13%612,437$1.34M1
14No dataJushi Hldgs Inc Swap Nbc-L2.00%2,603,144$1.26M1
15912797UM7United States Treasury Bill 11/05/20261.88%1,180,000$1.18M22

Showing 1–15 of 36 holdings

CNBS Performance

Launched Jul 23, 2019

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
CNBS$8,365
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,199
Oct 31, 2025 to Oct 30, 2026. CNBS $8,365. SPY $11,199. Use the arrow keys to read each point.$7,500$10,000$12,500$15,000Oct 2025Apr 2026Oct 2026

Oct 31, 2025 – Oct 30, 2026

Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for CNBS. Periods over one year show the average yearly return.
PeriodCNBS
Year to date−19.6%
1 month−12.7%
3 months−8.3%
1 year−16.3%
3 yearsper year−8.5%
5 yearsper year−30.5%
10 yearsFund is under 10 years oldper yearNo data

With distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for CNBS
YearReturn barCNBS
2026 YTD−19.6%
2025+15.3%
2024−29.1%

CNBS in the news

CNBS Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 30, 2026.
0.00%Last 12 months
Payout per share
NoneLast 12 months

No distributions in the last 12 months.

Distribution history

Payments through 2024

One bar per payment. 4 payments from 2019 to 2024. Dec 30, 2019 $0.92; Dec 29, 2020 $1.21; Dec 29, 2021 $0.0019; Dec 30, 2024 $10.71. Use the arrow keys to read each point.201920202021202220232024
Ex-datePay dateAmount per share
Dec 30, 2024Dec 31, 2024$10.71
Dec 29, 2021Dec 31, 2021$0.0019
Dec 29, 2020Dec 31, 2020$1.21
Dec 30, 2019Jan 2, 2020$0.92

$10,000 in CNBS 5 years ago paid $505 in dividends.

CNBS Risk

Risk pillarC44 out of 100Rank 2 of 5 in Cannabis
How much the fund’s monthly returns vary, scaled to a year.
74.6%
Annualised · 36 months to Oct 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.12
vs 3-month T-bills · to Oct 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−91.2%
Trough Jun 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.92
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FMP measures it over up to five years of monthly returns.

CNBS Cost

Compare CNBS and WEED

Overpaying vs WEED, cheapest in Cannabis

$6,375

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • CNBS 0.76%

    $14,656

  • WEED 0.41% Cheapest

    $8,281

$10,000
30 years

Cost over time

  • CNBS 0.76%
  • WEED 0.41%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K051015202530CNBS $14,656WEED $8,281

Year by year

YearCNBSWEEDOverpaying
10$1,353$741$612
20$5,142$2,860$2,282
30$14,656$8,281$6,375
How the 0.76% is worked out

Full fee 1.09%− waiver 0.33%= you pay 0.76%

The waiver ends Mar 1, 2027. After that the fee is 1.09% unless Amplify renews it. Source: prospectus, Jan 2026.

Other funds in Cannabis

See others